Skip to main content
logo
Straumann Holding AG (SWX:STMN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
95.24
-8.36 (-8.07%)
Aug 13, 2025, 5:35 PM CET

Oncternal Therapeutics Revenue

Straumann Holding AG had revenue of 1.23B CHF in the half year ending December 31, 2024, with 7.72% growth. This brings the company's revenue in the last twelve months to 2.58B, up 7.18% year-over-year. In the year 2024, Straumann Holding AG had annual revenue of 2.50B with 9.98% growth.

Revenue (ttm)
2.58B
Revenue Growth
+7.18%
P/S Ratio
5.89
Revenue / Employee
222.72K
Employees
11,815
Market Cap
15.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.50B227.21M9.98%
Dec 31, 20232.28B-44.10M-1.90%
Dec 31, 20222.32B298.88M14.78%
Dec 31, 20212.02B596.05M41.80%
Dec 31, 20201.43B-170.37M-10.67%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Roche Holding AG63.49B
Novartis AG43.89B
Lonza Group AG7.09B
Alcon8.77B
Galderma Group AG3.73B
Sandoz Group AG8.42B
Sonova Holding AG3.87B
Ypsomed Holding AG748.87M
Revenue Rankings

Straumann Holding AG News

More News